Abstract
Due to the narrow associations between the skin, immune system, and nervous system, nerve endings are very important in the pathophysiology of inflammatory dermatoses and especially in atopic dermatitis. Many neurotransmitters and nerve growth factors that are released in blood or skin are involved in neurogenic inflammation, which dramatically enhance the inflammation induced by immune cells. During times of stress, their release is highly enhanced. In atopic dermatitis lesions, there are many specific changes in skin neurobiology and neurophysiology. These interesting data suggest that novel therapeutic possibilities can be imagined.
Similar content being viewed by others
References
Cooper KD (1994) Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 102:128–137
Chateau Y, Misery L (2004) Connections between nerve endings and epidermal cells: are they synapses? Exp Dermatol 13:2–4
Langerhans P (1868) Uber die Nerven der menschlichen Haut. Virchows Arch Pathol Anat Physiol 44:325–337
Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A et al (1993) Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363:159–163
Gaudillere A, Misery L, Souchier C, Claudy A, Schmitt D (1996) Intimate associations between PGP9.5-positive nerve fibres and Langerhans cells. Br J Dermatol 135:343–344
Hilliges M, Wang L, Johansson O (1995) Ultrastructural evidence for nerve fibers within all vital layers of the human epidermis. J Invest Dermatol 104:134–137
Wiesner-Menzel L, Schulz B, Vakilzadeh F, Czarnetzki BM (1981) Electron microscopal evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol 61:465–469
Sueki H, Telegan B, Murphy GF (1995) Computer-assisted three-dimensional reconstruction of human dermal dendrocytes. J Invest Dermatol 105:704–708
Lotti T, Hautmann G, Panconesi E (1995) Neuropeptides in skin. J Am Acad Dermatol 33:482–496
Eedy DJ, Shaw C, Johnston CF, Buchanan KD (1994) The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography. Clin Exp Dermatol 19:463–472
Boissel JP, Ohly D, Bros M, Gödtel-Armbrust U, Förstermann U, Frank S (2004) The neuronal nitric oxide synthase is upregulated in mouse skin repair and in response to epidermal growth factor in human HaCaT keratinocytes. J Invest Dermatol 123:132–139
Boulais N, Misery L (2007) Merkel cells. J Am Acad Dermatol 57:147–165
Misery L (1997) Skin, immunity and the nervous system. Br J Dermatol 137:843–850
Cocchia D, Michetti F, Donato R (1981) Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin. Nature 294:85–87
Misery L, Campos L, Sabido O, Kanitakis J, Dezutter-Dambuyant C, Guyotat D et al (1993) S100 protein and neuron-specific enolase on monocytic leukemic CD1+ cells, probable precursors of Langerhans cells. Eur J Haematol 51:132–135
Hsieh ST, Choi S, Lin WM, Chang YC, McArthur JC, Griffin JW (1996) Epidermal denervation and its effects on keratinocytes and Langerhans cells. J Neurocytol 25:513–524
Hamzeh H, Gaudillere A, Sabido O, Tchou I, Lambert C, Schmitt D et al (2000) Expression of PGP9.5 on Langerhans’ cells and their precursors. Acta Derm Venereol 80:14–16
Bhardwaj RS, Luger TA (1994) Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis. Arch Dermatol Res 287:85–90
Staniek V, Misery L, Peguet-Navarro J, Abello J, Doutremepuich JD, Claudy A et al (1997) Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P. Arch Dermatol Res 289:285–291
Staniek V, Misery L, Peguet-Navarro J, Sabido O, Cuber JC, Dezutter-Dambuyant C et al (1996) Expression of gastrin-releasing peptide receptor in human skin. Acta Derm Venereol 76:282–286
Shimizu T, Streilein JW (1994) Influence of alpha-melanocyte-stimulating hormone on induction of contact hypersensitivity and tolerance. J Dermatol Sci 8:187–193
Misery L (1998) Langerhans cells in the neuro–immuno–cutaneous system. J Neuroimmunol 89:83–87
Gillardon F, Moll I, Michel S, Benrath J, Weihe E, Zimmerman M (1995) CGRP and nitric oxide are involved in UV radiation-induced immunosuppression. Eur J Pharamacol Environ Toxic 296:395–400
Hosoi J, Torii H, Fox F, Zan Z, Rook AH, Granstein RD (1995) Alteration of cytokine expression by calcitonin gene-related peptide (CGRP). J Invest Dermatol 105:859
Asahina A, Hosoi J, Beissert S, Stratigos A, Granstein RD (1995) Inhibition of the induction of delayed-type and contact hyeprsensitivity by CGRP. J Immunol 154:3056–3061
Misery L (2000) The neuro–immuno–cutaneous system and ultraviolet radiation. Photodermatol Photoimmunol Photomed 16:78–81
Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D (1996) Skin–nervous system interactions. J Invest Dermatol 106:198–204
Lambert RW, Granstein RD (1998) Neuropeptides and Langerhans cells. Exp Dermatol 7:73–80
Lotti T, Bianchi B, Panconesi E (1999) Neuropeptides and skin disorders. The new frontiers of neuro–endocrine–cutaneous immunology. Int J Dermatol 38:673–675
Pincelli C, Fantini F, Gianetti A (1993) Neuropeptides and skin inflammation. Dermatology 187:153–158
Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81–96
Luger TA, Lotti T (1998) Neuropeptides: role in inflammatory skin diseases. J Eur Acad Dermatol Venereol 10:207–211
Marconi A, Terracina M, Fila C, Franchi J, Bonte F, Romagnoli G et al (2003) Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol 121:1515–1521
Pincelli C, Fantini F, Giannetti A (1994) Nerve growth factor and the skin. Int J Dermatol 33:308–312
Freund V, Kassel O, Frossard N (2001) Le facteur de croissance des nerfs: un nouveau médiateur de l’inflammation ? Rev Fr Allergol Immunol Clin 41:571–578
Buske-Kirschbaum A, Hellhammer D (2003) Endocrine and immune responses to stress in chronic inflammatory skin disorders. Ann NY Acad Sci 992:231–240
Slominski A, Wortsman J, Tuckey RC, Paus R (2007) Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol 265–266:143–149
Al’Abadie MSK, Senior HJ, Bleehen SS, Gawkrodger DJ (1994) Neuropeptides and neuronal marker in atopic dermatitis: a quantified immunohistochemical study. Eur J Dermatol 4:394–398
Tobin D, Nabarro G, De La Faille HB, Van Vloten WA, Van Der Putte SC, Schuurman HJ (1992) Increased number of nerve fibers in atopic dermatitis. J Allergy Clin Immunol 90:613–622
Pincelli C, Fantini F, Massimi P, Girolimoni G, Seidenari S, Giannetti A (1990) Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 122:745–750
Pincelli C, Fantini FPM, Gianetti A (1990) Neuropeptide Y-like immunoreactivity in Langerhans cells from patients with atopic dermatitis. J Neurosci 51:219–220
Johansson O, Liu PY, Han SW, Lindberger M, Ljungdahl A, Wahl-Gren CF (1995) An immunohistochemical study of neuroactive substances in the skin of atopic dermatitis. Eur J Dermatol 5:516–523
Rupprecht M, Renders U, Koch HU, Hornstein OP (1993) Twenty-four hour secretion of prolactin in patients with atopic eczema and normal controls. Eur J Dermatol 3:495–498
Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M (2002) Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147:71–79
Umemoto N, Kakurai M, Okazaki H, Kiyosawa T, Demitsu T, Nakagawa H (2003) Serum levels of vasoactive intestinal peptide are elevated in patients with atopic dermatitis. J Dermatol Sci 31:161–164
Gordon DJ, Ostlere LS, Holden CA (1997) Neuropeptide modulation of Th1 and Thé cytokines in peripheral blood mononuclear leukocytes in atopic dermatitis and non-atopic controls. Br J Dermatol 137:921–927
Kim KH, Park KC, Chung JH, Choi HR (2003) The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis. J Dermatol Sci 32:115–124
Antunez C, Torres MJ, Lopez S, Rodriguez-Pena R, Blanca M, Mayorga C et al (2009) Calcitonin gene-related peptide modulates interleukin-13 in circulating cutaneous lymphocyte-associated antigen-positive T cells in patients with atopic dermatitis. Br J Dermatol 161:547–553
Wessler I, Reinheimer T, Kilbinger H, Bittinger F, Kirkpatrick CJ, Saloga J et al (2003) Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. Life Sci 72:2169–2172
Kindt F, Wiegand S, Niemeier V, Kupfer J, Loser C, Nilles M et al (2008) Reduced expression of nicotinic alpha subunits 3, 7, 9 and 10 in lesional and nonlesional atopic dermatitis skin but enhanced expression of alpha subunits 3 and 5 in mast cells. Br J Dermatol 159:847–857
Munoz-Hoyos A, Espin-Quirantes C, Molina-Carballo A, Uberos J, Contreras-Chova F, Narbona-Lopez E et al (2007) Neuroendocrine and circadian aspects (melatonin and beta-endorphin) of atopic dermatitis in the child. Pediatr Allergy Immunol 18:679–686
Kim TH, Jung JA, Kim GD, Jang AH, Ahn HJ, Park YS et al (2009) Melatonin inhibits the development of 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. J Pineal Res 47:324–329
Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D (1995) Increased concentration of beta-endorphin in the sera of patients with severe atopic dermatitis. Acta Derm Venereol 75:9–11
Tominaga M, Ogawa H, Takamori K (2007) Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. J Invest Dermatol 127:2228–2235
Bigliardi-Qi M, Lipp B, Sumanovski LT, Buechner SA, Bigliardi PL (2005) Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 210:91–99
Schlessinger J, Miller B, Gilbert RD, Plott RT (2006) An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis. Arch Dermatol 142:1568–1572
Patel L, Clayton PE, Addison GM, Price DA, David TJ (1995) Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol 132:950–955
Paul-Eugene N, Kolb JP, Damais C, Abadie A, Mencia-Huerta JM, Braquet P et al (1994) Beta 2-adrenoceptor agonists regulate the IL-4-induced phenotypical changes and IgE-dependent functions in normal human monocytes. J Leukoc Biol 55:313–320
Niemeier V, Gieler U, Baerwald C, Kupfer J, Schill WB, Happle R (1996) Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with atopic dermatitis. Eur J Dermatol 6:377–380
Potter PC, Van Wyk L, Martin M, Lentes KU, Dowdle EB (1993) Genetic polymorphism of the beta-2 adrenergic receptor in atopic and non-atopic subjects. Clin Exp Allergy 23:874–877
Schallreuter KU, Wei Y, Pittelkow MR, Swanson NN, Gibbons NC, Wood JM (2007) Structural and functional alterations in the beta2-adrenoceptor are caused by a point mutation in patients with atopic eczema. Exp Dermatol 16:807–813
Roguedas AM, Audrezet MP, Scotet V, Dupre-Goetghebeur D, Ferec C, Misery L (2006) Intrinsic atopic dermatitis is associated with a beta-2 adrenergic receptor polymorphism. Acta Derm Venereol 86:447–448
Schallreuter KU, Pittelkow MR, Swanson NN, Beazley WD, Korner C, Ehrke C et al (1997) Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema. Arch Dermatol Res 289:663–666
Misery L, Roguedas AM (2004) Atopie et stress. Ann Dermatol Vénéréol 131:1008–1011
Sugiura H, Omoto M, Hirota Y, Danno K, Uehara M (1997) Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 289:125–131
Dou YC, Hagstromer L, Emtestam L, Johansson O (2006) Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 298:31–37
Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z (2009) Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 53:48–54
Takano N, Sakurai T, Ohashi Y, Kurachi M (2007) Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model. Br J Dermatol 156:241–246
Grewe M, Vogelsang K, Ruzicka T, Stege H, Krutmann J (2000) Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J Invest Dermatol 114:1108–1112
Ma L, Gao XH, Zhao LP, Di ZH, McHepange UO, Zhang L et al (2009) Brain-derived neurotrophic factor gene polymorphisms and serum levels in Chinese atopic dermatitis patients. J Eur Acad Dermatol Venereol 23:1277–1281
Tominaga M, Ogawa H, Takamori K (2008) Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. Br J Dermatol 158:842–844
Yamaguchi J, Nakamura F, Aihara M, Yamashita N, Usui H, Hida T et al (2008) Semaphorin3A alleviates skin lesions and scratching behavior in NC/Nga mice, an atopic dermatitis model. J Invest Dermatol 128:2842–2849
Tominaga M, Tengara S, Kamo A, Ogawa H, Takamori K (2009) Psoralen-ultraviolet a therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci 55:40–46
Wahlgren CF, Ekblom A (1996) Two-point discrimation of itch in patients with atopic dermatitis and healthy subjects. Acta Derm Venereol 76:48–51
Heyer GR, Hortsein OP (1999) Recent studies of cutaneous nociception in atopic and non-atopic subjects. J Dermatol 26:77–86
Koppert W, Heyer G, Handwerker H (1996) Atopic eczema and histamine-induced sensations. Dermatology 192:227–232
Mori T, Ishida K, Mukumoto S, Yamada Y, Imokawa G, Kabashima K et al (2010) Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis. Br J Dermatol 162(1):83–90
Ozawa M, Tsuchiyama K, Gomi R, Kurosaki F, Kawamoto Y, Aiba S (2009) Neuroselective transcutaneous electrical stimulation reveals neuronal sensitization in atopic dermatitis. J Am Acad Dermatol 60:609–614
Engel-Yeger B, Habib-Mazawi S, Parush S, Rozenman D, Kessel A, Shani-Adir A (2007) The sensory profile of children with atopic dermatitis as determined by the sensory profile questionnaire. J Am Acad Dermatol 57:610–615
Shani-Adir A, Rozenman D, Kessel A, Engel-Yeger B (2009) The relationship between sensory hypersensitivity and sleep quality of children with atopic dermatitis. Pediatr Dermatol 26:143–149
Grosshans E, Selig D, Quenneville Y, Gautherie M (1977) Physiopathologie de la blancheur cholinergique retardée dans l’atopie. Ann Dermatol Vénéréol 104:453–457
Eishi K, Lee JB, Bae SJ, Takenaka M, Katayama I (2002) Impaired sweating function in adult atopic dermatitis: results of the quantitative sudomotor axon reflex test. Br J Dermatol 147:683–688
Cicek D, Kandi B, Berilgen MS, Bulut S, Tekatas A, Dertliogu SB et al (2008) Does autonomic dysfunction play a role in atopic dermatitis? Br J Dermatol 159:834–838
Boettger MK, Bär KJ, Dohrmann A, Müller H, Mertins L, Brockmeyer NH et al (2009) Increased vagal modulation in atopic dermatitis. J Dermatol Sci 53:55–59
Misery L (2001) Are biochemical mediators the missing link between psychosomatics and dermatology ? Dermatol Psychosom 2:178–183
Slominski A, Mihm MC (1996) Potential mechanism of skin response to stress. Int J Dermatol 35:849–851
Walker CD, Bodnar M, Forget MA, Toufexis DJ, Trottier G (1997) Stress et plasticité neuroendocrinienne. Med Sci 13:509–518
Dhabhar FS (1998) Stress-induced enhancement of cell-mediated immunity. Ann NY Acad Sci 840:359–372
Dhabhar FS (1999) Mac Ewen BS. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA 96:1059–1064
Harbuz MS, Conde GL, Marti O, Lightman SL, Jessop DS (1997) The hypothalamic–pituitary–adrenal axis in autoimmunity. Ann NY Acad Sci 823:214–224
Misery L, Rousset H (2001) La pelade est-elle une maladie psychosomatique ? Rev Méd Interne 22:274–279
Sandberg S, Paton JY, Ahola S, Mac Cann DC, Mac Guinness D, Hillary CR et al (2000) The role of acute and chronic stress in asthma attacks in children. Lancet 356:982–987
Kodama A, Horikawa T, Suzuki T, Ajiki W, Takashima T, Harada S et al (1999) Effect of stress on atopic dermatitis: investigation in patients after the great Hanshin earthquake. J Allergy Clin Immunol 104:173–176
Misery L, Thomas L, Jullien D, Cambazard F, Humbert P, Dubertret L et al (2008) Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatology. Eur J Dermatol 18:412–415
Chida Y, Hamer M, Steptoe A (2008) A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 70:102–116
Buske-Kirschbaum A, Geiben A, Hellhammer D (2001) Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 70:6–16
Von Hertzen LC (2002) Maternal stress and T-cell differentiation of the developing immune system: possible implications for the development of asthma and atopy. J Allergy Clin Immunol 109:923–928
Buske-Kirschbaum A, Gierens A, Hollig H, Hellhammer DH (2002) Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 129:161–167
Saint-Mézard P, Chavagnac C, Bosset S, Ionescu M, Peyron E, Kaiserlian D et al (2003) Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J Immunol 171:4073–4080
Katayama I, Bae SJ, Hamasaki Y, Igawa K, Miyazaki Y, Yokozeki H et al (2001) Stress response, tachykinin and cutaneous inflammation. J Invest Dermatol Symp Proc 6:81–86
Arndt J, Smith N, Tausk F (2008) Stress and atopic dermatitis. Curr Allergy Asthma Rep 8:312–317
Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold KR et al (2001) Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 137:53–59
Pavlovic S, Daniltchenko M, Tobin DJ, Hagen E, Hunt SP, Klapp BF et al (2008) Further exploring the brain–skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 128:434–446
Drake LA, Fallon JD, Sober A (1994) Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol 31:613–616
Kawana S, Kato Y, Omi T (2010) Efficacy of a 5-HT1a receptor agonist in atopic dermatitis. Clin Exp Dermatol 35(8):835–840
Stander S, Stander H, Seeliger S, Luger TA, Steinhoff M (2007) Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol 156:1020–1026
Pereira U, Boulais N, Lebonvallet N, Pennec JP, Dorange G, Misery L (2010) Mechanisms of sensory effects of tacrolimus on the skin. Br J Dermatol 163(1):70–77
Darsow U, Pfab F, Valet V, Huss-Marp J, Behrendt H, Ring J et al. (2010) Pruritus and atopic dermatitis. Clin Rev Allergy Immunol (in press)
Ulven T, Kostenis E (2010) Novel CRTH2 antagonists: a review of patents from 2006 to 2009. Expert Opin Ther Pat 20:1505–1530
Misery L (2005) Atopic dermatitis and psychism. Ann Dermatol Vénéréol 132(suppl 1):112–115
Chida Y, Steptoe A, Hirakawa N, Sudo N, Kubo C (2007) The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis. Int Arch Allergy Immunol 144:1–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Misery, L. Atopic Dermatitis and the Nervous System. Clinic Rev Allerg Immunol 41, 259–266 (2011). https://doi.org/10.1007/s12016-010-8225-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-010-8225-z